AICAR ZPHC — 250 mg (5 vials × 50 mg)
ALSO KNOWN AS
- 5-Aminoimidazole-4-carboxamide ribonucleotide
- AICA-riboside
- AMPK Activator
DESCRIPTION
ZPHC AICAR is a research-grade metabolic modulator that activates AMP-activated protein kinase (AMPK), a key energy-sensing enzyme in cells. This kit contains 5 lyophilized vials of 50 mg each, totaling 250 mg. AICAR is studied for its potential to enhance endurance, stimulate glucose uptake in muscles, and promote fat metabolism. Its mechanism mimics the effects of exercise at the cellular level, making it of interest in obesity, metabolic, and performance-related research models.
DOSAGE & ADMINISTRATION
- Form: Lyophilised peptide
• Strength: 50 mg per vial
• Total: 250 mg (5 vials)
• Reconstitution: Add 1–2 ml bacteriostatic water per vial
• Suggested Research Dosage: 10–50 mg daily depending on protocol
• Route: Subcutaneous or intravenous injection in research settings
CYCLE USE
Often used in models exploring fat loss, glucose metabolism, enhanced mitochondrial activity, and performance enhancement. May be stacked with GW501516 or other endurance-enhancing compounds in experimental setups.
PACKAGE CONTENTS
5 vials × 50 mg (Total: 250 mg)
STORAGE INSTRUCTIONS
- Store lyophilised vials at room temperature
- After reconstitution, refrigerate at 2–8 °C
- Use within 7–10 days of reconstitution
- Protect from light and do not freeze
